Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032509076> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3032509076 endingPage "276" @default.
- W3032509076 startingPage "272" @default.
- W3032509076 abstract "ObjectiveTo evaluate the efficiency of HLH-04 protocol on children with EBV-hemophagocytic lymphohistiocytosis (EBV-HLH).MethodsThe clinical features, rates of therapeutic response and prognosis of 12 children with EBV-HLH which were diagnosed and treated in the department of Pediatrics, Second Affiliated Hospital, Sun Yat-Sen University during April 2005 to April 2008, were retrospectively analyzed. All patients fulfilled the diagnostic criteria for EBV-HLH according to the HLH-04 protocol, namely, positivity for the EBV genome and positive anti-viral antibody in the blood. The therapeutic protocol was based on the HLH-04 protocol with some changes if the effect was poor or the side effects of drugs were serious, such as teniposide instead of etoposide, cellcept instead of cyclosporine A, or cellcept + cyclosporine A instead of etoposide.Results①Clinical features: All the 12 EBV-HLH patients had persistent hyperpyrexia, splenomegaly and hematocytopenia. 1 had convulsion. Serum ferritin in 8 cases was over 500 mg/L, triacylglycerol in 6 cases was over 3.0 mmol/L, fibrinogen in 5 cases was less than 1.5 g/L, the amount of the natural killer cell in 8 cases was decreased, and the hemophagocytosis was found in 12 cases of bone marrow biopsy examination. ②Treatment response: 1 patient quit the treatment after final diagnosis, and the median follow-up time of the other 11 patients were 17 months (10~36 months). During the early stage of treatment, the median time for complete remission (CR) was 21 days. 10 achieved complete remission at the 14th~42th day, 1 could not achieve remission (NR) after 112 days, but teniposide and cellcept was given and the patient achieved complete remission at day 118 and kept continue complete remission (CCR) finally. During the maintenance stage, 9 patients achieved continue complete remission and their continue complete remission time was 9~32 months. And 8 cases withdrew drus, the time of drug withdrawal were 1~19 months, 1 patient lost follow-up after 11 months of treatment because of relapse. 1 patient relapsed 10 months later after drug withdrawal, who was receiving drug treatment subsequently.ConclusionMost of EBV-HLH children can be effectively controlled by immunochemical therapy based on the HLH-04 protocol. Etoposide can be replaced with teniposide if its effect is bad; and cellcept is another feasible choice for those who are not tolerant CsA or cannot achieve good effect.Key words: hemophagocytic lymphohistiocytosis; histiocytosis; hemophagocytic lymphohistiocytosis-04(HLH-04); child" @default.
- W3032509076 created "2020-06-05" @default.
- W3032509076 creator A5050233080 @default.
- W3032509076 creator A5060401991 @default.
- W3032509076 creator A5067131328 @default.
- W3032509076 creator A5082985248 @default.
- W3032509076 creator A5086110855 @default.
- W3032509076 date "2009-06-01" @default.
- W3032509076 modified "2023-09-26" @default.
- W3032509076 title "Treatment of EBV-Hemophagocytic Lymphohistiocytosis With Hemophagocytic Lymphohistiocytosis-04 Protocol." @default.
- W3032509076 doi "https://doi.org/10.3877/cma.j.issn.1673-5250.2009.03.116" @default.
- W3032509076 hasPublicationYear "2009" @default.
- W3032509076 type Work @default.
- W3032509076 sameAs 3032509076 @default.
- W3032509076 citedByCount "0" @default.
- W3032509076 crossrefType "journal-article" @default.
- W3032509076 hasAuthorship W3032509076A5050233080 @default.
- W3032509076 hasAuthorship W3032509076A5060401991 @default.
- W3032509076 hasAuthorship W3032509076A5067131328 @default.
- W3032509076 hasAuthorship W3032509076A5082985248 @default.
- W3032509076 hasAuthorship W3032509076A5086110855 @default.
- W3032509076 hasConcept C126322002 @default.
- W3032509076 hasConcept C187212893 @default.
- W3032509076 hasConcept C203014093 @default.
- W3032509076 hasConcept C2776694085 @default.
- W3032509076 hasConcept C2777363875 @default.
- W3032509076 hasConcept C2778119113 @default.
- W3032509076 hasConcept C2779079688 @default.
- W3032509076 hasConcept C2779134260 @default.
- W3032509076 hasConcept C2779382419 @default.
- W3032509076 hasConcept C2780007613 @default.
- W3032509076 hasConcept C71924100 @default.
- W3032509076 hasConcept C90924648 @default.
- W3032509076 hasConceptScore W3032509076C126322002 @default.
- W3032509076 hasConceptScore W3032509076C187212893 @default.
- W3032509076 hasConceptScore W3032509076C203014093 @default.
- W3032509076 hasConceptScore W3032509076C2776694085 @default.
- W3032509076 hasConceptScore W3032509076C2777363875 @default.
- W3032509076 hasConceptScore W3032509076C2778119113 @default.
- W3032509076 hasConceptScore W3032509076C2779079688 @default.
- W3032509076 hasConceptScore W3032509076C2779134260 @default.
- W3032509076 hasConceptScore W3032509076C2779382419 @default.
- W3032509076 hasConceptScore W3032509076C2780007613 @default.
- W3032509076 hasConceptScore W3032509076C71924100 @default.
- W3032509076 hasConceptScore W3032509076C90924648 @default.
- W3032509076 hasIssue "3" @default.
- W3032509076 hasLocation W30325090761 @default.
- W3032509076 hasOpenAccess W3032509076 @default.
- W3032509076 hasPrimaryLocation W30325090761 @default.
- W3032509076 hasRelatedWork W2029130963 @default.
- W3032509076 hasRelatedWork W2034486605 @default.
- W3032509076 hasRelatedWork W2103654950 @default.
- W3032509076 hasRelatedWork W2154593185 @default.
- W3032509076 hasRelatedWork W2363119258 @default.
- W3032509076 hasRelatedWork W2376097454 @default.
- W3032509076 hasRelatedWork W2402821501 @default.
- W3032509076 hasRelatedWork W2419562918 @default.
- W3032509076 hasRelatedWork W2550555600 @default.
- W3032509076 hasRelatedWork W2557392973 @default.
- W3032509076 hasRelatedWork W2567377994 @default.
- W3032509076 hasRelatedWork W2606953123 @default.
- W3032509076 hasRelatedWork W2740980328 @default.
- W3032509076 hasRelatedWork W2945423825 @default.
- W3032509076 hasRelatedWork W2980219400 @default.
- W3032509076 hasRelatedWork W2992522291 @default.
- W3032509076 hasRelatedWork W3030155437 @default.
- W3032509076 hasRelatedWork W3032992773 @default.
- W3032509076 hasRelatedWork W3043717456 @default.
- W3032509076 hasRelatedWork W3047537798 @default.
- W3032509076 hasVolume "5" @default.
- W3032509076 isParatext "false" @default.
- W3032509076 isRetracted "false" @default.
- W3032509076 magId "3032509076" @default.
- W3032509076 workType "article" @default.